Indivior Pharmaceuticals (INDV) Equity Ratio (2021 - 2026)
Indivior Pharmaceuticals has reported Equity Ratio over the past 6 years, most recently at 0.12 for Q1 2026.
- For Q1 2026, Equity Ratio rose 41.96% year-over-year to 0.12; the TTM value through Mar 2026 reached 0.12, up 41.96%, while the annual FY2025 figure was 0.08, 68.14% up from the prior year.
- Equity Ratio for Q1 2026 was 0.12 at Indivior Pharmaceuticals, down from 0.08 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.01 in Q4 2022 and troughed at 0.26 in Q4 2024.
- A 5-year average of 0.15 and a median of 0.15 in 2025 define the central range for Equity Ratio.
- Biggest five-year swings in Equity Ratio: tumbled 1134.34% in 2023 and later skyrocketed 68.14% in 2025.
- Year by year, Equity Ratio stood at 0.01 in 2022, then tumbled by 1134.34% to 0.1 in 2023, then tumbled by 144.67% to 0.26 in 2024, then skyrocketed by 68.14% to 0.08 in 2025, then crashed by 47.43% to 0.12 in 2026.
- Business Quant data shows Equity Ratio for INDV at 0.12 in Q1 2026, 0.08 in Q4 2025, and 0.15 in Q3 2025.